ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$103M |
| 2 |
Coinbase
COIN
|
+$77.6M |
| 3 |
Ginkgo Bioworks
DNA
|
+$40.4M |
| 4 |
Twilio
TWLO
|
+$33.2M |
| 5 |
Prime Medicine
PRME
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fate Therapeutics
FATE
|
+$140M |
| 2 |
NVIDIA
NVDA
|
+$126M |
| 3 |
Spotify
SPOT
|
+$62.8M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$62.2M |
| 5 |
SGFY
Signify Health, Inc.
SGFY
|
+$61.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.12% |
| 2 | Technology | 34.23% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Communication Services | 7.68% |
| 5 | Financials | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
26
DELISTED
Verve Therapeutics
VERV
| $84.5M | 0.73% |
4,365,830
+971,971
| +29% | +$25.8M |
|
27
Kratos Defense & Security Solutions
KTOS
$11.4B
| $80M | 0.69% |
7,748,357
-441,287
| -5% | -$4.39M |
|
28
Iridium Communications
IRDM
$5.29B
| $76.8M | 0.67% |
1,494,455
-274,325
| -16% | -$13.8M |
|
|
29
NVIDIA
NVDA
$5.42T
| $76.5M | 0.66% |
5,231,810
-8,594,430
| -62% | -$126M |
|
30
Incyte
INCY
$24.4B
| $76.3M | 0.66% |
950,393
-79,796
| -8% | -$6.11M |
|
31
Schrodinger
SDGR
$1.36B
| $72M | 0.62% |
3,852,037
+87,330
| +2% | +$1.81M |
|
32
CareDx
CDNA
$2.42B
| $70.6M | 0.61% |
6,188,182
+401,062
| +7% | +$5.94M |
|
33
Adaptive Biotechnologies
ADPT
$3.97B
| $70.3M | 0.61% |
9,201,245
-135,374
| -1% | -$1.05M |
|
34
Deere & Co
DE
$168B
| $64.4M | 0.56% |
150,253
-26,415
| -15% | -$10.7M |
|
35
Mercado Libre
MELI
$92.3B
| $64.3M | 0.56% |
75,982
-13,298
| -15% | -$11.8M |
|
36
Cerus
CERS
$474M
| $57.9M | 0.5% |
15,863,384
-990,491
| -6% | -$3.73M |
|
|
TWOU
37
DELISTED
2U Inc
TWOU
| $57.5M | 0.5% |
305,534
-8,223
| -3% | -$1.63M |
|
38
AeroVironment
AVAV
$9.45B
| $55.2M | 0.48% |
644,045
-106,146
| -14% | -$9.08M |
|
|
NVTA
39
DELISTED
Invitae Corporation
NVTA
| $50.4M | 0.44% |
27,072,844
-3,395,537
| -11% | -$8.29M |
|
40
Teradyne
TER
$59.3B
| $48.5M | 0.42% |
555,038
+2,720
| +0.5% | +$233K |
|
|
41
Fate Therapeutics
FATE
$326M
| $42.5M | 0.37% |
4,214,863
-7,440,970
| -64% | -$140M |
|
|
ACCD
42
DELISTED
Accolade Inc
ACCD
| $42.5M | 0.37% |
5,458,916
-459,449
| -8% | -$4.39M |
|
|
RPTX
43
DELISTED
Repare Therapeutics
RPTX
| $35.7M | 0.31% |
2,428,055
-203,973
| -8% | -$3.05M |
|
44
Vertex Pharmaceuticals
VRTX
$126B
| $35.3M | 0.31% |
122,197
-35,248
| -22% | -$10.7M |
|
45
Arcturus Therapeutics
ARCT
$211M
| $34.1M | 0.3% |
2,012,429
-169,274
| -8% | -$2.95M |
|
46
Veeva Systems
VEEV
$37.4B
| $34.1M | 0.3% |
211,478
-17,722
| -8% | -$3.03M |
|
|
MTLS
47
Materialise
MTLS
$396M
| $31.6M | 0.27% |
3,592,979
-2,269,019
| -39% | -$22.5M |
|
|
48
Prime Medicine
PRME
$559M
| $30.5M | 0.26% |
+1,639,984
| New | +$29.6M |
|
49
monday.com
MNDY
$3.94B
| $30.4M | 0.26% |
249,493
-12,256
| -5% | -$1.27M |
|
50
908 Devices
MASS
$364M
| $28.1M | 0.24% |
3,689,475
-85,719
| -2% | -$1.04M |
|
Similar funds
ARK Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, ARK Investment Management held 255 positions worth $11.5B, down 20% from $14.3B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
ARK Investment Management withdrew a net $790M in Q4 2022, closing 23 positions and reducing 163 holdings. Its most notable exit was Signify Health, Inc., an estimated $61.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 37% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, ARK Investment Management opened a new position in Prime Medicine worth $30.5M.
- ARK Investment Management's largest Q4 2022 buy was Prime Medicine: 1,639,984 shares worth $30.5M.
- ARK Investment Management added most to Tesla in Q4 2022, an estimated $103M increase.
- ARK Investment Management's biggest Q4 2022 reduction was Fate Therapeutics, cutting an estimated $140M.
- ARK Investment Management fully exited Signify Health, Inc. in Q4 2022, selling an estimated $61.1M.
- ARK Investment Management's ten largest holdings make up 46% of its $11.5B portfolio in Q4 2022.
- ARK Investment Management opened 5 new positions and closed 23 in Q4 2022.
- ARK Investment Management's portfolio value fell 20% quarter-over-quarter to $11.5B.
Based on ARK Investment Management's 13F filing for Q4 2022, filed 24 Jan 2023.